Regeneron Pharmaceuticals
REGN
#168
Rank
$79.54 B
Marketcap
$725.05
Share price
0.01%
Change (1 day)
4.66%
Change (1 year)

Operating Margin for Regeneron Pharmaceuticals (REGN)

Operating Margin as of May 2023 (TTM): 39.91%

According to Regeneron Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 39.91%. At the end of 2021 the company had an Operating Margin of 58.03%.

Operating Margin history for Regeneron Pharmaceuticals from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202158.03%29.4%
202044.84%45.17%
201930.89%-18.82%
201838.05%7.5%
201735.40%29.37%
201627.36%-8.35%
201529.85%8.51%
201427.51%-18.82%
201333.89%12.74%
201230.06%-160.13%
2011-50.00%119.7%
2010-22.76%19.95%
2009-18.97%-43.7%
2008-33.70%-63.19%
2007-91.55%-46.05%
2006-169.68%-190.27%
2005187.97%5693.39%
20043.24%-101.87%
2003-173.90%-68.65%
2002-554.63%42.23%
2001-389.95%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
24.28%-39.16%๐Ÿ‡บ๐Ÿ‡ธ USA
16.16%-59.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
34.79%-12.83%๐Ÿ‡บ๐Ÿ‡ธ USA
19.90%-50.14%๐Ÿ‡ซ๐Ÿ‡ท France
36.44%-8.69%๐Ÿ‡บ๐Ÿ‡ธ USA
-100.93%-352.89%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.